Generian Pharmaceuticals
PrivateLast Round
Seed
Oct 1, 2019
Total Funding Raised
$13M
Company Overview
Generian Pharmaceuticals is a preclinical biotechnology company that discovers and develops orally available small molecule therapeutics for diseases with high unmet needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Generian Pharmaceuticals Comparables
Compare Generian Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dunad Therapeutics | 84% | |
| E3 Therapeutics Inc. | 83% | |
| Talus Bio | 82% | |
Generian Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 1, 2019 |
Key People
Founding team and executive leadership
Generian Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pittsburgh Innovation Institute | Seed |
| UPMC Enterprises | Seed |
Generian Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Generian Pharmaceuticals's valuation, stock price, and market status.